#1 Clinical Trials Search in Europe

Anhydrous Ropivacaine Hydrochloride

This article discusses a clinical trial investigating the use of Anhydrous Ropivacaine Hydrochloride, a local anesthetic, in combination with patient-controlled sedation for the repair of obstetric perineal lacerations. The study aims to improve patient comfort and experiences during this common postpartum procedure. We’ll explore the trial’s objectives, eligibility criteria, and potential benefits for new mothers undergoing perineal repair after childbirth.

Table of Contents

What is Ropivacaine?

Anhydrous Ropivacaine Hydrochloride, commonly known as Ropivacaine, is a local anesthetic medication. Local anesthetics are drugs that numb a specific area of the body, reducing pain sensations. Ropivacaine belongs to a class of medications called amide local anesthetics.[1]

Medical Use in Obstetrics

Ropivacaine is primarily used in obstetric care, specifically for the repair of obstetric perineal lacerations. These are tears that can occur in the perineum (the area between the vagina and anus) during childbirth. The medication is used to provide pain relief during the repair of these tears.[1]

How is Ropivacaine Administered?

In the context of repairing obstetric perineal lacerations, Ropivacaine is typically administered through a pudendal nerve block. This involves injecting the medication near the pudendal nerve, which provides sensation to the perineal area. The maximum daily dose is 100 mg, and it’s usually given as a single treatment.[1]

Current Clinical Trial

A clinical trial is currently being conducted to investigate the effectiveness of adding patient-controlled sedation with propofol to the standard Ropivacaine pudendal nerve block for repairing obstetric perineal lacerations. The main objective of this study is to assess patient pain/discomfort and complications when this combined approach is used.[1]

Who Can Receive Ropivacaine in the Trial?

The trial has specific criteria for who can participate. Eligible participants include:

  • Adult patients (18 years or older)
  • Patients scheduled for examination and repair of grade I or II perineal lacerations
  • Patients who have given informed consent to participate in the study

However, certain conditions may exclude a patient from participating, such as:

  • BMI greater than 35
  • Preeclampsia or hypertensive disease
  • Postpartum hemorrhage greater than 1000 ml
  • Known or suspected allergy to any medication in the study
  • Functional disability in both hands that affects the ability to operate the patient-controlled sedation device
  • Cognitive impairment or language difficulties that make it hard to understand the study or operate the device
  • Perineal lacerations of grade III-IV

These criteria ensure the safety of participants and the reliability of the study results.[1]

Potential Benefits

The use of Ropivacaine in repairing obstetric perineal lacerations may offer several potential benefits:

  • Reduced pain and discomfort during the repair procedure
  • Decreased anxiety before and during the procedure
  • Possibility of skin-to-skin contact with the baby during the repair
  • Potentially faster recovery and earlier mobilization after the procedure

These potential benefits are being studied in the current clinical trial to determine their extent and significance.[1]

Important Considerations

While Ropivacaine is generally considered safe for its intended use, it’s important to note:

  • As with any medication, there may be potential side effects or allergic reactions.
  • The effectiveness and patient experience may vary from person to person.
  • This medication should only be administered by trained healthcare professionals in appropriate medical settings.
  • Always inform your healthcare provider about any allergies, medical conditions, or medications you’re taking before receiving any treatment.

Remember, the information provided here is based on a specific clinical trial and may not represent all possible uses or effects of Ropivacaine. Always consult with your healthcare provider for personalized medical advice.[1]

Aspect Details
Study Drug Anhydrous Ropivacaine Hydrochloride (local anesthetic)
Medical Condition Obstetric perineal lacerations (grades I and II)
Main Objective Investigate pain/discomfort and complications when adding patient-controlled sedation to standard pudendal nerve block
Study Design Randomized controlled trial with two groups: control (pudendal nerve block only) and intervention (pudendal nerve block + PCS with propofol)
Primary Outcome Pain/discomfort during the procedure
Key Secondary Outcomes Preprocedural anxiety, repair time, skin-to-skin contact ability, time to micturition, patient experience
Inclusion Criteria Adult patients (≥18 years), planned repair of grade I or II perineal laceration, informed consent
Key Exclusion Criteria BMI > 35, preeclampsia, postpartum hemorrhage > 1000 ml, allergies to study medications, cognitive impairment

FAQ

  • What is the main purpose of this clinical trial? The main purpose of this clinical trial is to investigate whether adding patient-controlled sedation with propofol to the standard pudendal nerve block improves patient pain and discomfort during the repair of obstetric perineal lacerations (grades I and II).
  • What is Anhydrous Ropivacaine Hydrochloride used for in this study? Anhydrous Ropivacaine Hydrochloride is used as a local anesthetic for the pudendal nerve block, which is part of the standard procedure for repairing perineal lacerations after childbirth.
  • Who is eligible to participate in this clinical trial? Eligible participants are adult patients (18 years or older) who require examination and repair of perineal laceration grades I or II. They must provide informed consent and meet other specific criteria, such as having a BMI below 35 and no history of certain medical conditions.
  • What are the main outcomes being measured in this study? The primary outcome being measured is pain and discomfort during the procedure. Secondary outcomes include preprocedural anxiety, time of repair, ability to have skin-to-skin contact with the baby during repair, and various postpartum factors such as time until micturition and need for pain relief.
  • How is the study designed? The study is designed as a randomized controlled trial. Eligible patients will be randomly assigned to either the control group (receiving only pudendal nerve block) or the intervention group (receiving pudendal nerve block plus patient-controlled sedation with propofol).

Ongoing Clinical Trials on Anhydrous Ropivacaine Hydrochloride

  • Study on Patient-Controlled Sedation with Propofol for Women Undergoing Repair of Obstetric Perineal Tears Using Ropivacaine, Lidocaine, and Mepivacaine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

Glossary

  • Anhydrous Ropivacaine Hydrochloride: A local anesthetic medication used to numb specific areas of the body. In this study, it's used for pudendal nerve blocks during perineal laceration repair.
  • Perineal Laceration: A tear in the area between the vagina and anus that can occur during childbirth. Grades I and II are less severe tears involving the skin and muscles of the perineum.
  • Pudendal Nerve Block: A type of local anesthesia that numbs the area around the vagina and anus by injecting anesthetic near the pudendal nerve.
  • Patient-Controlled Sedation (PCS): A method allowing patients to self-administer small doses of a sedative medication (in this case, propofol) as needed for comfort during a medical procedure.
  • Propofol: A short-acting medication used for sedation during medical procedures. In this study, it's used in the patient-controlled sedation device.
  • Randomized Controlled Trial: A type of scientific study where participants are randomly assigned to different treatment groups to compare the effects of interventions.
  • BMI (Body Mass Index): A measure of body fat based on height and weight. In this study, participants must have a BMI below 35 to be eligible.
  • Micturition: The medical term for urination. The study measures the time until first micturition after the perineal repair procedure.
  • Skin-to-skin contact: Direct contact between a mother's bare skin and her newborn baby's skin, which is beneficial for bonding and the baby's development.

References

  1. http://clinicaltrials.eu/trial/study-on-patient-controlled-sedation-with-propofol-for-women-undergoing-repair-of-obstetric-perineal-tears-using-ropivacaine-lidocaine-and-mepivacaine/